SEC Form 4 · accession 0001615774-15-002389
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zachary McAdoo
Director
Period of report
Aug 20, 2015
Accepted (ET)
Aug 24, 2015 · 6:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF1 | $0.055 | Aug 20, 2015 | A | 250,000 | A | — | Aug 19, 2025 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1These options vest pro rata over 36 months beginning on August 20, 2015.